These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3009589)

  • 21. Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status.
    Moretti S; Lanza F; Spisani S; Latorraca A; Rigolin GM; Giuliani AL; Castoldi GL; Traniello S
    Leuk Lymphoma; 1994 May; 13(5-6):471-7. PubMed ID: 8069192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil specific granule deficiency.
    Gallin JI
    Annu Rev Med; 1985; 36():263-74. PubMed ID: 3888052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways.
    Brown GE; Reed EB; Lanser ME
    J Immunol; 1991 Aug; 147(3):965-71. PubMed ID: 1650389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: clinical and laboratory approach to the management of neutrophil dysfunction.
    Wolach B; Baehner RL; Boxer LA
    Isr J Med Sci; 1982 Sep; 18(9):897-916. PubMed ID: 6754659
    [No Abstract]   [Full Text] [Related]  

  • 25. Human neutrophil gelatinase is a component of specific granules.
    Hibbs MS; Bainton DF
    J Clin Invest; 1989 Nov; 84(5):1395-402. PubMed ID: 2553773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid micromeasurement of neutrophil exocytosis.
    Webster RO; Henson PM
    Inflammation; 1978 Jun; 3(2):129-35. PubMed ID: 216633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of exocytosis in early neutrophil activation.
    Sengeløv H; Kjeldsen L; Borregaard N
    J Immunol; 1993 Feb; 150(4):1535-43. PubMed ID: 8381838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L; O'Reilly D; Klempner MS; Rocklin RE
    J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actin assembly and regulation of neutrophil function: effects of cytochalasin B and tetracaine on chemotactic peptide-induced O2- production and degranulation.
    Bengtsson T; Dahlgren C; Stendahl O; Andersson T
    J Leukoc Biol; 1991 Mar; 49(3):236-44. PubMed ID: 1847714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils.
    Lew PD; Monod A; Waldvogel FA; Dewald B; Baggiolini M; Pozzan T
    J Cell Biol; 1986 Jun; 102(6):2197-204. PubMed ID: 3011810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal-sized primary lysosomes are present in Chediak-Higashi syndrome neutrophils.
    White JG; Krumwiede M
    Pediatr Res; 1987 Aug; 22(2):208-15. PubMed ID: 2821473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic disorders of leukocyte function: what they tell us about normal antimicrobial mechanisms of human phagocytic cells.
    Root RK; Beeson PB
    Klin Wochenschr; 1982 Jul; 60(14):731-4. PubMed ID: 6289003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of neutrophil function.
    Bogomolski-Yahalom V; Matzner Y
    Blood Rev; 1995 Sep; 9(3):183-90. PubMed ID: 8563520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential expression of cell surface C3bi receptors during neutrophil locomotion.
    Francis JW; Todd RF; Boxer LA; Petty HR
    J Cell Physiol; 1989 Sep; 140(3):519-23. PubMed ID: 2528551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of phagocytic function: ultrastructural aspects.
    Douglas SD
    Prog Clin Biol Res; 1977; 13():141-55. PubMed ID: 323873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects of neutrophil function.
    Johnston RB
    N Engl J Med; 1982 Aug; 307(7):434-6. PubMed ID: 7088117
    [No Abstract]   [Full Text] [Related]  

  • 37. The Chediak-Higashi syndrome: quantitation of a deficiency in maximal bactericidal capacity.
    Clawson CC; Repine JE; White JG
    Am J Pathol; 1979 Mar; 94(3):539-47. PubMed ID: 106731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative inactivation of myeloperoxidase released from human neutrophils.
    Edwards SW; Nurcombe HL; Hart CA
    Biochem J; 1987 Aug; 245(3):925-8. PubMed ID: 2822034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Chédiak-Higashi syndrome; the nature of the giant neutrophil granules and their interactions with cytoplasm and foreign particulates. I. Progressive enlargement of the massive inclusions in mature neutrophils. II. Manifestations of cytoplasmic injury and sequestration. III. Interactions between giant organelles and foreign particulates.
    White JG; Clawson CC
    Am J Pathol; 1980 Jan; 98(1):151-96. PubMed ID: 6243205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts.
    Odell EW; Segal AW
    Biochim Biophys Acta; 1988 Oct; 971(3):266-74. PubMed ID: 2844290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.